Literature DB >> 8195805

Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges.

R Nau1, F Sörgel, H W Prange.   

Abstract

Physicochemical properties of drugs were related to their ability to enter the cerebrospinal fluid (CSF) in humans by reevaluation of previously reported studies. Either the quotients of the drug concentrations in CSF and serum at steady state (CCSFSS/CSSS) or, since in most cases CSF passage was studied after a short-term infusion, the ratios of the areas under the concentration-time curves in CSF and serum (AUCCSF/AUCS) were taken as measures of CSF passage. AUCS and CSSS were corrected for binding to serum proteins (AUCSf, CSssf). Of the drugs studied the quotient of the octanol/water partition coefficient at pH 7.4 (PC) as a measure of lipophilicity and the square root of the molecular weight (MW1/2) correlated with AUCCSF/AUCS (Spearman's rank correlation coefficient rS = 0.78, P < 0.01) and with AUCCSF/AUCSf (rS = 0.90, P < 0.01). PC.MW-1/2 was related to AUCCSF/AUCSf (or CCSFSS/CSssf, respectively) by the equation: AUCCSF/AUCSf = 0.96 + 0.091.1n(PC.MW-1/2). For 0.0001 < or = PC.MW-1/2 < or = 1.0 this function may be of value for the prediction of CSF penetration in humans when the physicochemical properties of a drug are known and when active transport or metabolism are negligible.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195805     DOI: 10.1016/0022-510x(94)90052-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

1.  Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits.

Authors:  L F López-Cortés; R Ruiz-Valderas; M J Lucero-Muñoz; E Cordero; M T Pastor-Ramos; J Marquez
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.

Authors:  Masahiro Takahata; Hiroshi Yamada; Teiichi Morita; Shinichi Furubou; Shinzaburo Minami; Yozo Todo; Yasuo Watanabe; Hirokazu Narita
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis.

Authors:  Christian Ostergaard; Dorthe Sandvang; Niels Frimodt-Møller; Hans-Henrik Kristensen
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

Review 4.  Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.

Authors:  Sungmin Kiem; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

5.  Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.

Authors:  R Nau; M Kinzig-Schippers; F Sörgel; S Schinschke; R Rössing; C Müller; H Kolenda; H W Prange
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

6.  Gemifloxacin is effective in experimental pneumococcal meningitis.

Authors:  A Smirnov; A Wellmer; J Gerber; K Maier; S Henne; R Nau
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

7.  Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.

Authors:  W Liu; Q F Liu; R Perkins; G Drusano; A Louie; A Madu; U Mian; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 8.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

9.  Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

Authors:  R Nau; H W Prange; M Kinzig; A Frank; A Dressel; P Scholz; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

10.  Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.

Authors:  R Nau; C Lassek; M Kinzig-Schippers; A Thiel; H W Prange; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.